![NEJM on Twitter: "PSA screening for prostate cancer should involve consideration of benefits and risks. Screening is associated with a small reduction in prostate cancer deaths; risks include overdiagnosis and unnecessary biopsy NEJM on Twitter: "PSA screening for prostate cancer should involve consideration of benefits and risks. Screening is associated with a small reduction in prostate cancer deaths; risks include overdiagnosis and unnecessary biopsy](https://pbs.twimg.com/media/FtruscpaEAAHW1o.jpg)
NEJM on Twitter: "PSA screening for prostate cancer should involve consideration of benefits and risks. Screening is associated with a small reduction in prostate cancer deaths; risks include overdiagnosis and unnecessary biopsy
![Integrated workflow for urinary prostate specific antigen N-glycosylation analysis using sdAb partitioning and downstream capillary electrophoresis separation - ScienceDirect Integrated workflow for urinary prostate specific antigen N-glycosylation analysis using sdAb partitioning and downstream capillary electrophoresis separation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003267021007182-ga1.jpg)
Integrated workflow for urinary prostate specific antigen N-glycosylation analysis using sdAb partitioning and downstream capillary electrophoresis separation - ScienceDirect
![Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men | Prostate Cancer and Prostatic Diseases Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41391-021-00367-8/MediaObjects/41391_2021_367_Fig1_HTML.png)
Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men | Prostate Cancer and Prostatic Diseases
![Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA | Science Translational Medicine Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.3001970/asset/728179a1-18ad-4e40-9da3-193bbecb74f8/assets/graphic/3-94ra72-f1.jpeg)
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA | Science Translational Medicine
![Towards the differential diagnosis of prostate cancer by the pre-treatment of human urine using ionic liquids | Scientific Reports Towards the differential diagnosis of prostate cancer by the pre-treatment of human urine using ionic liquids | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-71925-8/MediaObjects/41598_2020_71925_Fig1_HTML.png)